Announcements Trials
Browse Landscape

Phase

Phase 2 28Phase 1 14Phase 1/2 7Phase 3 6Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 4Terminated 1Recruiting 1

Sponsor Class

OTHER 3NIH 1NETWORK 1INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 6Other solid neoplasm 6

Conditions

Carcinoma, Non-Small-Cell Lung 156Lung Neoplasms 57Uterine Cervical Neoplasms 53Squamous Cell Carcinoma of Head and Neck 52Nasopharyngeal Carcinoma 51Head and Neck Neoplasms 47Stomach Neoplasms 37Parkinson Disease 4, Autosomal Dominant Lewy Body 35Esophageal Neoplasms 31Urinary Bladder Neoplasms 26Small Cell Lung Carcinoma 21Esophageal Squamous Cell Carcinoma 21Ovarian Neoplasms 19Carcinoma 14Neoplasm Metastasis 13Cholangiocarcinoma 13Recurrence 11Neuroblastoma 11Nasopharyngeal Neoplasms 11Carcinoma, Ovarian Epithelial 11Biliary Tract Neoplasms 11Adenocarcinoma Of Esophagus 11Neoplasms 10Gallbladder Neoplasms 10Carcinoma, Transitional Cell 10Testicular Neoplasms 9Adenocarcinoma of Lung 9Teratoma 8Oropharyngeal Neoplasms 8Endometrial Neoplasms 8

Interventions

Cisplatin 6Pemetrexed 4Carboplatin 3Nivolumab 2Ipilimumab 2tumor necrosis factor-alpha, CNGRC fusion protein, human 1ranpirnase 1raltitrexed 1durvalumab 1atezolizumab 1Vinorelbine 1Vincristine 1Talc 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Psychiatric Rehabilitation 1Platinum 1Mitomycin 1Injections 1Gemcitabine 1Fentanyl 1Drug Therapy 1Doxorubicin 1Cerebral Decortication 1Analgesia 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × Mesothelioma, Malignant × Cisplatin × Clear all
NCT04158141 2026-05-19

Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma

NRG Oncology

Phase 3 Terminated
16 enrolled 18 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT06097728 2026-04-28

eVOLVE-Meso

AstraZeneca

Phase 3 Recruiting
825 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT04334759 2026-01-22

DREAM3R

PrECOG, LLC.

Phase 3 Completed
214 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT00075699 2013-08-07

Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma

National Cancer Institute (NCI)

Phase 3 Completed
840 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT00005636 2013-06-19

Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery

Memorial Sloan Kettering Cancer Center

Phase 3 Completed
Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT00004920 2012-07-18

Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
256 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡